Cardiovascular and Economic Outcomes After Initiation of Lipid-Lowering Therapy With Atorvastatin vs Simvastatin in an Employed Population

Authors:

Abstract
No abstract available
Funding Information
  • Pfizer

This publication has 36 references indexed in Scilit: